Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 25.03% vs -2.28% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 113.42% vs 1.72% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -7.65% vs -2.96% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 206.77% vs 11.82% in Mar 2024
Compare Profit and Loss Results of Ambar Protein
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
421.00
1,830.00
-1,409.00
-76.99%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
421.00
1,830.00
-1,409.00
-76.99%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-4.00
4.00
100.00%
Raw Materials Consumed
395.00
1,703.00
-1,308.00
-76.81%
Power & Fuel Cost
3.00
23.00
-20.00
-86.96%
Employee Cost
1.00
22.00
-21.00
-95.45%
Operating Expenses
1.00
42.00
-41.00
-97.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
4.00
-2.00
-50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
405.00
1,804.00
-1,399.00
-77.55%
Operating Profit (PBDIT) excl Other Income
15.00
26.00
-11.00
-42.31%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
16.00
28.00
-12.00
-42.86%
Interest
2.00
3.00
-1.00
-33.33%
Profit before Depriciation and Tax
14.00
25.00
-11.00
-44.00%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
22.00
-9.00
-40.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
22.00
-9.00
-40.91%
Provision for Tax
3.00
4.00
-1.00
-25.00%
Profit After Tax
9.00
18.00
-9.00
-50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
18.00
271.00
-253.00
-93.36%
Profit Available for appropriations
27.00
289.00
-262.00
-90.66%
Appropriations
27.00
289.00
-262.00
-90.66%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
16.78
57.39
-40.61
-70.76%
Profit And Loss - Net Sales
Net Sales 421.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.03% vs -2.28% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 113.42% vs 1.72% in Mar 2024
Profit And Loss - Interest
Interest 2.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.65% vs -2.96% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 9.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 206.77% vs 11.82% in Mar 2024






